Pharmaceutical Technology-04-02-2005

Pharmaceutical Technology

Analytical Methods Validation In-Process Control Methods for the Manufacture of Active Pharmaceutical Ingredients

April 02, 2005

Articles

29

4

The authors propose a strategy for classifying and validating inprocess testing methods.

April 2005

April 02, 2005

Articles

29

4

Pharmaceutical Science and Technology News

Management Controls for GMP Compliance

April 02, 2005

Articles

29

4

Managers of FDA-regulated firms must be proactive in how they manage their company?s compliance with good manufacturing practices regulations.

The Sector Chart: A New Engineering Graph for Pharmaceutical Processes

April 02, 2005

Articles

29

4

The author proposes a new analytical graphic, the sector chart, which presents data that cannot be adequately presented with current graphs.This chart combines features of zone charts with the basic principle of precontrol charts. It addresses engineering control and is superior for representing data such as beneficial and adverse trends.

Validation of Alternative Microbiology Methods for Product Testing Quantitative and Qualitative Assays

April 02, 2005

Articles

29

4

The validation of alternative microbiological testing is an opportunity for a manufacturer to decrease the amount of time required for laboratory results.To properly validate these alternatives, a practitioner must first identify what is being studied. The regulatory effect on established product and process specifications and levels must be completely evaluated, as changing the method of analysis may well change the pparent number in the sample.

PAT and Process Understanding: A Call to Arms

April 02, 2005

Articles

29

4

The C-SOC team must develop a network of committed industrial partners who will participate in the direction, execution, and evaluation of research and educational activities.

Cold Chain Concerns

April 02, 2005

Articles

29

4

RFID and battery-powered containers are among the developments receiving attention in the pharmaceutical cold chain.

Evolutions in Direct Compression

April 02, 2005

Articles

29

4

The principles of direct compression haven’t changed in more than a century. So why can the topic still pack a ballroom?

X-ray Microtomography of Solid Dosage Forms

April 02, 2005

Articles

29

4

X-ray microtomography has great potential for improving the understanding of the structural features of solid dosage forms and the changes in those features during manufacturing, handling, and storage.This article describes the basic principles of the technique and provides examples of its potential applications.

Orient Express

April 02, 2005

29

4

Achieving the promised benefits of offshore sourcing to India and China is more complicated than it seems.

Importance of Background Microbial Levels in the Manufacture and Testing of Sterile Products

April 02, 2005

Articles

29

4

The sterility testing of samples from an aseptic process may be considered an entirely separate aseptic process that is subject to the same types of adventitious contamination as the aseptic process itself.

Using Visible Residue Limits for Introducing New Compounds into a Pharmaceutical Research Facility

April 02, 2005

Articles

29

4

An increasing number of new compounds are being introduced into pharmaceutical pilot plants.The knowledge base for these compounds regarding their toxicities,physical handling, and cleaning is limited.The authors examine various approaches for addressing the cleaning validation of new compounds and discuss the role of determining appropriate visible residue limits.

Comparative Evaluation of Three Active Air Samplers for the Monitoring of Airborne Microorganisms

April 02, 2005

Articles

29

4

A comparative study of three air samplers used for bioaerosol collection was performed to evaluate the average recovery of colony-forming units and assess the precision of each device.

Famine in Field Inspection

April 02, 2005

Articles

29

4

What the industry needs most is not reduced oversight. What we need is, competent, constructive, informed, consistent, fair, and predictable inspection.

Establishing Target Fills for Semisolid and Liquid Dosage Forms

April 02, 2005

Articles

29

4

To meet the requirements of the USP ^755& Minimum Fill and ^698& Deliverable Volume tests, target fill levels greater than 100% must be established.This article proposes a criterion for establishing an appropriate target fill level such that a sample will have a 95% probability of passing these USP tests at 95% confidence.

Isolator Decontamination Using Chlorine Dioxide Gas

April 02, 2005

Articles

29

4

The authors argue that chlorine dioxide (CD) is a safe and effective decontaminating agent that can be used for challenging applications.The effectiveness of CD gas for sterilizing complex isolator systems is studied.

In the Spotlight - April 2005

April 02, 2005

Articles

29

4

Pharmaceutical Science and Technology Innovations

US Pharmacopeia’s Convention 2005

April 02, 2005

Articles

29

4

At its 2005 Convention, USP passed 13 resolutions that will help define the organization’s path for the next five years and represent the interests of its diverse constituency.

Compression and Mechanical Properties of Tablet Formulations: Containing Corn, Sweet Potato, and Cocoyam Starches as Binders

April 02, 2005

Articles

29

4

The authors study the effects of sweet potato and cocoyam starches on the compressional and mechanical characteristics of a paracetamol tablet formulation using cornstarch BP.

Generic Drug Battles Heat Up

April 02, 2005

Articles

29

4

Innovators and generics makers are staking out positions on follow-on proteins and other manufacturing issues.